UB - University at Buffalo, The State University of New York Chemical and Biological Engineering

CBE News

  • October 26, 2016
    Andreadis receives two new NIH grants Stelios T. Andreadis, CBE Professor and Chair, received two new NIH R01 grants. The first from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to study reprogramming of skin cells into neural crest stem cells and their derivatives including neurons, and Schwann cells. The work aims to provide a novel source of abundant, readily accessible, autologous stem cells for treatment of neurodegenerative diseases, such as devastating myelopathies (e.g. multiple sclerosis, spinal cord injuries and others) for which cell sourcing remains a severe impediment hampering cell therapy approaches. Dr. Fraser Sim (UB, Pharmacology and Toxicology) and Dr. Marianne Bonner (Division of Biology and Biological Engineering, Caltech) are co-Investigators. The second is a multi PI R01 with Dr. Olga Baker (University of Utah) from the National Institute of Dental and Craniofacial Research. The work aims to develop functionalized biomaterials to promote salivary gland regeneration for treatment of debilitating diseases that cause salivary gland dysfunction such as Sjögren’s syndrome, ectodermal dysplasia and γ-irradiation therapies for head and neck cancers.
  • August 30, 2016
    Mojtaba Haghighatlari (Hachmann lab) won the Outstanding Student Poster Award of the ACS Division of Physical Chemistry during the ongoing 2016 ACS National Meeting in Philadelphia, and also the "Scholarship Award for Scientific Excellence of the ACS Division of Chemical Information".
  • August 30, 2016
    UB CBE PhD Student Mohammad Atif Faiz Afzal was just awarded the American Physical Society Distinguished Student Travel Award, which includes a travel bursary and a speaking slot at the 2017 APS March Meeting in New Orleans.
  • August 3, 2016
    UB PhDs Charles Jones and Mahmoud Ahmadi win 2nd place in Panasci competition--The Henry A. Panasci Jr. Technology Entrepreneurship Competition was created by the UB School of Management and the UB Office of Science, Technology Transfer and Economic Outreach. Funded with a $1 million endowment from the late Henry A. Panasci Jr., the program brings together UB students from science, technology, business and other disciplines to maximize their potential and create viable businesses in Western New York. UB CBE PhDs Charles Jones of Bear Creek, North Carolina, Mahmoud Kamal Ahmadi of Torbat-e Jam, Iran, and Blaine Pfeifer, associate professor will collect $10,000 for their venture, Shay Bioproducts, a precious metal retrieval unit used to recover and reuse pricy metals for their second-place prize. All participants will be offered co-working space in dig, part of the Thomas R. Beecher Jr. Innovation Center.
  • August 3, 2016
    UB CBE alumni and student take top prize at Bright Buffalo Niagara Competition--Charles Jones and Marie Beitelshees were recently selected for participation in Bright Buffalo Niagara, a local entrepreneurial competition to encourage commercial translation of their prior and ongoing doctoral research projects. The pair were representing Abcombi Biosciences, a vaccine development company Jones formed in 2015 together with CBE faculty member Blaine Pfeifer, and claimed the grand prize which included a $20,000 cash award. Jones is the CEO of Abcombi Biosciences while Beitelshees is completing her Ph.D. under Dr. Pfeifer
  • August 3, 2016
    Making injectable medicine safer--UB CBE professor Paschalis Alexandridis and BME assistant professor and UB CBE adjunct assistant professor Jon Lovell, along with UB CBE PhD student Yumiao Zhang have developed a new drug-making technique that could lead to safer forms of injectable medicine. The goal is to reduce serious allergic reactions and other side effects from a variety of drugs including anti-cancer medicine, testosterone and other drugs administered through a needle. The breakthrough removes potentially harmful additives – primarily soapy substances known as surfactants – from common injectable drugs. Pharmaceutical companies use surfactants to dissolve medicine into a liquid solution, a process that makes medicine suitable for injection. While effective, the process is seldom efficient. Solutions loaded with surfactant and other nonessential ingredients can carry the risk of causing anaphylactic shock, blood clotting, hemolysis and other side effects. The work was described in a study, “Therapeutic Surfactant-Stripped Frozen Micelles ,” and was published in the journal Nature Communications. [read more] Additional UB faculty and staff authors on the paper are: Javid Rzayev, PhD, associate professor and Dinesh K. Sukumaran, PhD, director of the Magnetic Resonance Center, both in the Department of Chemistry in UB’s College of Arts and Sciences, Wentao Song, Upendra Chitgupi, Jumin Geng, Jasmin Federizon and Hande Unsal. The research was supported by a National Institutes of Health grant.
  • August 2, 2016
    Embryonic gene Nanog reverses aging in adult stem cells--in a series of experiments at the University at Buffalo, UB CBE Professor Stelios Andreadis and PhD Panos Mistriotis and have found that the embryonic stem cell gene named Nanog shows promise in counteracting premature aging disorders including preventing weak bones, clogged arteries and other telltale signs of growing old. “Our research into Nanog is helping us to better understand the process of aging and ultimately how to reverse it,” says Stelios T. Andreadis, PhD, professor and chair of the Department of Chemical and Biological Engineering at the UB School of Engineering and Applied Sciences, and the study’s lead author. Additional authors come from UB’s Department of Biomedical Engineering, a joint program between UB’s engineering school and the Jacobs School of Medicine and Biomedical Sciences at UB, and the Department of Biostatistics and Bioinformatics at Roswell Park Cancer Institute in Buffalo. [read more]
  • July 29, 2016
    Stelios Andreadis has been selected to be Fellow of BMES for contributions in the fields of Stem Cells, Molecular Bioengineering, Tissue Engineering and Regenerative Medicine. He will be publicly recognized at the Class of 2016 Fellows during the BMES Annual Meeting to be held October 5-8, 2016, in Minneapolis, MN
  • July 29, 2016
    Professor Ed Furlani will lead R&D team for $1.48M Buffalo Institute for Genomics and Data Analytics project. Professor Edward Furlani has worked with local startup company Garwood Medical Devices LLC (GMD) to secure $1.48M in funding from the Buffalo Institute for Genomics and Data Analytics (BIG). BIG is a University at Buffalo program and key component of Gov. Andrew M. Cuomo’s $100 million initiative to transform New York State into a national center for genomic medicine research. The contract with GMD will create 40 new jobs in five years. GMD, a medical device company participating in the START-UP NY program, is developing a new class of programmable electrical stimulation devices with integrated sensor and communications technologies to enable unprecedented treatment for chronic wound healing, bone growth and peri-prosthetic (implant) infections, while simultaneously enhancing quality of life by enabling enhanced patient mobility and decreasing the need for clinician intervention. Dr. Furlani will lead the research and development team, leveraging UB’s comprehensive faculty expertise in device processes, modeling and design, prototype fabrication and characterization, software communications, high performance computing and bioinformatics to aid GMD on their commercialization path.
  • April 13, 2016
    Congratulations to Anna C. Smith, our most recent Goldwater Scholarship Winner. UB CBE is proud to add Anna to the ranks of six winners since 2012! Anna's goal is to complete a Ph.D. in chemical engineering and become an interdisciplinary researcher. She would like to start a company based on the innovative research and development of materials and electronics.
<   / 5 >